GLP1 ETF Fixed
Today’s Change (Jun 22, 2026)
—
A symphony is an automated trading strategy — Learn more about symphonies here
About
Owns the steadier of Eli Lilly (LLY) or Novo Nordisk (NVO) based on 10‑day price swings, with roughly 50% kept in cash to cut risk. No regular rebalancing; it changes only when the calmer pick switches.
It watches two drug makers—Eli Lilly (LLY) and Novo Nordisk (NVO). Every day it looks back 10 trading days and picks the one with smaller price swings. About half the portfolio goes into that stock and the other half stays in cash. It doesn’t rebalance on a set schedule; it only switches if the calmer stock changes.
GLP-1 focused strategy with a 50% cash overlay targets outsized upside: ~32% annualized return vs ~18% for SPY. Calmar ~1.32 signals solid risk-adjusted growth, though Sharpe trails SPY and max drawdown is higher. Growth-focused, risk-aware investors.
1M
3M
6M
YTD
1Y
3Y
Max
Performance
Compared to selected benchmarks
| Alpha | Beta | R2 | R | |
|---|---|---|---|---|
| 0.14 | 0.59 | 0.16 | 0.4 |
Performance Metrics
| Cumulative Return | Annualized Return | Trailing 1M Return | Trailing 3M Return | Sharpe Ratio | |
|---|---|---|---|---|---|
| 2,644.8% | 10.78% | 0.09% | 13.88% | 0.64 | |
| 29,053.09% | 19.18% | -4.72% | 26.06% | 0.77 |
Initial Investment
$10,000.00
Final Value
$2,915,308.65Regulatory Fees
$6,106.76
Total Slippage
$44,200.26
Invest in this strategy
OOS Start Date
Sep 19, 2024
Trading Setting
Threshold 10%
Type
Stocks
Category
Equities, healthcare, pharmaceuticals, glp-1 theme, low-volatility, concentrated, cash overlay
Tickers in this symphonyThis symphony trades 2 assets in total
Ticker
Type
LLY
Eli Lilly & Co.
Stocks
NVO
Novo-Nordisk A/S
Stocks